Cardiac disease-free survival in patients with Thalassemia major treated with subcutaneous deferoxamine. An update of the Toronto Cohort

被引：0
|
作者：
机构：
来源：
| 1600年 / Publ by New York Acad of Sciences, New York, NY, USA卷 / 612期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy
    Hart, KB
    Wood, DP
    Tekyi-Mensah, S
    Porter, AT
    Pontes, JE
    Forman, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05): : 1235 - 1238
  • [42] Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Guerin
    Graham, Charles H.
    Pare, Jean-Francois
    Cotechini, Tiziana
    Hopman, Wilma
    Hindmarch, Charles C. T.
    Ghaffari, Abdi
    Marginean, Diana
    Chenard, Stephen
    Koti, Madhuri
    Siemens, D. Robert
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (08): : E412 - E417
  • [43] INFLUENCE OF METABOLIC SYNDROME ON OVERALL SURVIVAL (OS), DISEASE FREE SURVIVAL (DFS) AND INVASIVE FREE SURVIVAL (IFV) IN A COHORT OF PATIENTS TREATED FOR BREAST CANCER IN BRAZIL
    Antonini, Marcelo
    Guimaraes, Amanda Leal
    Richter, Fernanda Grace Bauk
    Ferraro, Odair
    Lopes, Reginaldo G. Coelho
    Real, Juliana M.
    Mattar, Andre
    CANCER RESEARCH, 2023, 83 (05)
  • [44] Conditional disease-free survival rates and their associated determinants in patients with epithelial ovarian cancer: A 15-year retrospective cohort study
    Ebrahimi, Vahid
    Khalafi-Nezhad, Abolfazl
    Ahmadpour, Fatemeh
    Jowkar, Zahra
    CANCER REPORTS, 2021, 4 (06)
  • [45] Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy
    Salgado, Lucas Resende
    Rhome, Ryan
    Oh, William
    Stone, Nelson
    Stock, Richard
    BRACHYTHERAPY, 2018, 17 (06) : 874 - 881
  • [46] Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy
    Lai, Jianguo
    Wang, Hongli
    Peng, Jingwen
    Chen, Peixian
    Pan, Zihao
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 2347 - 2356
  • [47] Which PSA Endpoint Best Predicts Disease-Free Survival in Prostate Cancer Patients Treated With Exclusive Radiation Therapy Combined With Hormones?
    Thouant, M.
    Bertaut, A.
    Pommier, P.
    Maingon, P.
    Martin, E.
    Quivrin, M.
    Vulquin, N.
    Ladoire, S.
    Cormier, L.
    Carrie, C.
    Crehange, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E234 - E234
  • [48] Prolonged disease-free survival in elderly relapsed diffuse large B-cell lymphoma patients treated with lenalidomide plus rituximab
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Argnani, Lisa
    Broccoli, Alessandro
    HAEMATOLOGICA, 2016, 101 (09)
  • [49] Mucinous histology to predict disease-free survival in microsatellite stable stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy
    Ahn, Joong Bae
    Kim, Se Hyun
    Shin, Sang Joon
    Lee, Kang Young
    Kim, Tae Il
    Hur, Hyuk
    Min, Byung Soh
    Kim, Nam Kyu
    Chung, Hyun Cheol
    Roh, Jae Kyung
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma
    Jung, Joonho
    Park, Seong Yong
    Park, Soo-jin
    Park, Jiye
    TUMOR BIOLOGY, 2016, 37 (06) : 7149 - 7154
12345